Results: 1-25 | 26-50 | 51-75 | 76-100 | >>

Table of contents of journal: *Bone marrow transplantation

Results: 1-25/396

Authors: Gordon, L
Citation: L. Gordon, Gemtuzumab Ozogamicin (Mylotarg) and hepatic veno-occlusive disease: take two acetaminophen, and, BONE MAR TR, 28(9), 2001, pp. 811-812

Authors: Sweetenham, JW
Citation: Jw. Sweetenham, Stem cell transplantation for mantle cell lymphoma: should it ever be usedoutside clinical trials?, BONE MAR TR, 28(9), 2001, pp. 813-820

Authors: Balasubramanian, P Chandy, M Krishnamoorthy, R Srivastava, A
Citation: P. Balasubramanian et al., Evaluation of existing limited sampling models for busulfan kinetics in children with beta thalassaemia major undergoing bone marrow transplantation, BONE MAR TR, 28(9), 2001, pp. 821-825

Authors: Chakraverty, R Robinson, S Peggs, K Kottaridis, PD Watts, MJ Ings, S Hale, G Waldmann, H Linch, DC Goldstone, AH Mackinnon, S
Citation: R. Chakraverty et al., Excessive T cell depletion of peripheral blood stem cells has an adverse effect upon outcome following allogeneic stem cell transplantation, BONE MAR TR, 28(9), 2001, pp. 827-834

Authors: Lazzarino, M Corso, A Barbarano, L Alessandrino, E Cairoli, R Pinotti, G Ucci, G Uziel, L Rodeghiero, F Fava, S Ferrari, D Fiumano, M Frigerio, G Isa, L Luraschi, A Montanara, S Morandi, S Perego, D Santagostino, A Savare, M Vismara, A Morra, E
Citation: M. Lazzarino et al., DCEP (dexamethasone, cyclophosphamide, etoposide, and cisplatin) is an effective regimen for peripheral blood stem cell collection in multiple myeloma, BONE MAR TR, 28(9), 2001, pp. 835-839

Authors: Le Blanc, R Montminy-Metivier, S Belanger, R Busque, L Fish, D Roy, DC Kassis, J Boileau, J Lavallee, R Belanger, D Letendre, F Hebert, J Sauvageau, G Perreault, C Roy, J
Citation: R. Le Blanc et al., Allogeneic transplantation for multiple myeloma: further evidence for a GVHD-associated graft-versus-myeloma effect, BONE MAR TR, 28(9), 2001, pp. 841-848

Authors: Blystad, AK Holte, H Kvaloy, S Smeland, E Delabie, J Kvalheim, G
Citation: Ak. Blystad et al., High-dose therapy in patients with Hodgkin's disease: the use of selected CD34(+) cells is as safe as unmanipulated peripheral blood progenitor cells, BONE MAR TR, 28(9), 2001, pp. 849-857

Authors: Morgan, RJ Doroshow, JH Leong, L Schriber, J Shibata, S Forman, S Hamasaki, V Margolin, K Somlo, G Alvarnas, J McNamara, M Longmate, J Raschko, J Chow, W Vasilev, S McGonigle, K Yen, Y
Citation: Rj. Morgan et al., Phase II trial of high-dose intravenous doxorubicin, etoposide, and cyclophosphamide with autologous stem cell support in patients with residual or responding recurrent ovarian cancer, BONE MAR TR, 28(9), 2001, pp. 859-863

Authors: Porrata, LF Ingle, JN Litzow, MR Geyer, S Markovic, SN
Citation: Lf. Porrata et al., Prolonged survival associated with early lymphocyte recovery after autologous hematopoietic stem cell transplantation for patients with metastatic breast cancer, BONE MAR TR, 28(9), 2001, pp. 865-871

Authors: Safdar, A van Rhee, F Henslee-Downey, JP Singhal, S Mehta, J
Citation: A. Safdar et al., Candida glabrata and Candida krusei fungemia after high-risk allogeneic marrow transplantation: no adverse effect of low-dose fluconazole prophylaxison incidence and outcome, BONE MAR TR, 28(9), 2001, pp. 873-878

Authors: Chakrabarti, S Collingham, KE Osman, H Fegan, CD Milligan, DW
Citation: S. Chakrabarti et al., Cidofovir as primary pre-emptive therapy for post-transplant cytomegalovirus infections, BONE MAR TR, 28(9), 2001, pp. 879-881

Authors: Morabito, F Irrera, G Oliva, E Console, G Martino, M Pucci, G Messina, G Barbaro, P Palazzo, S Iacopino, P
Citation: F. Morabito et al., Infectious complications in breast cancer patients undergoing peripheral blood stem cell transplantation: a single center retrospective analysis towards outpatient strategy, BONE MAR TR, 28(9), 2001, pp. 883-888

Authors: McGuire, TR Bociek, GR Pavletic, SZ Hock, L Lynch, J Schneider, J Hoie, EB Tarantolo, S Haire, WD
Citation: Tr. Mcguire et al., Organ dysfunction following stem cell transplantation: relationship to plasma cytokine concentrations, BONE MAR TR, 28(9), 2001, pp. 889-893

Authors: Tack, DK Letendre, L Kamath, PS Tefferi, A
Citation: Dk. Tack et al., Development of hepatic veno-occlusive disease after Mylotarg infusion for relapsed acute myeloid leukemia, BONE MAR TR, 28(9), 2001, pp. 895-897

Authors: Cornely, OA Pels, H Bethe, U Seibold, M Toepelt, K Soehngen, D Ritzkowsky, A
Citation: Oa. Cornely et al., A novel type of metastatically spreading subcutaneous aspergillosis without epidermal lesions following allogeneic stem cell transplantation, BONE MAR TR, 28(9), 2001, pp. 899-901

Authors: Oyama, Y Papadopoulos, EB Miranda, M Traynor, AE Burt, RK
Citation: Y. Oyama et al., Allogeneic stem cell transplantation for Evans syndrome, BONE MAR TR, 28(9), 2001, pp. 903-905

Authors: Vesole, DH Simic, A Lazarus, HM
Citation: Dh. Vesole et al., Controversy in multiple myeloma transplants: tandem autotransplants and mini-allografts, BONE MAR TR, 28(8), 2001, pp. 725-735

Authors: Johansson, JE Brune, M Ekman, T
Citation: Je. Johansson et al., The gut mucosa barrier is preserved during allogeneic, haemopoietic stem cell transplantation with reduced intensity conditioning, BONE MAR TR, 28(8), 2001, pp. 737-742

Authors: Bleyzac, N Souillet, G Magron, P Janoly, A Martin, P Bertrand, Y Galambrun, C Dai, Q Maire, P Jelliffe, RW Aulagner, G
Citation: N. Bleyzac et al., Improved clinical outcome of paediatric bone marrow recipients using a test dose and Bayesian pharmacokinetic individualization of busulfan dosage regimens, BONE MAR TR, 28(8), 2001, pp. 743-751

Authors: Jacobson, P Ng, J Ratanatharathorn, V Uberti, J Brundage, RC
Citation: P. Jacobson et al., Factors affecting the pharmacokinetics of tacrolimus (FK506) in hematopoietic cell transplant (HCT) patients, BONE MAR TR, 28(8), 2001, pp. 753-758

Authors: Chakrabarti, S Collingham, KE Holder, K Fegan, CD Osman, H Milligan, DW
Citation: S. Chakrabarti et al., Pre-emptive oral ribavirin therapy of paramyxovirus infections after haematopoietic stem cell transplantation: a pilot study, BONE MAR TR, 28(8), 2001, pp. 759-763

Authors: Schulenburg, A Watkins-Riedel, T Greinix, HT Rabitsch, W Loidolt, H Keil, F Mitterbauer, M Kalhs, P
Citation: A. Schulenburg et al., CMV monitoring after peripheral blood stem cell and bone marrow transplantation by pp65 antigen and quantitative PCR, BONE MAR TR, 28(8), 2001, pp. 765-768

Authors: Takatsuka, H Takemoto, Y Iwata, N Suehiro, A Hamano, T Okamoto, T Kanamaru, A Kakishita, E
Citation: H. Takatsuka et al., Oral eicosapentaenoic acid for complications of bone marrow transplantation, BONE MAR TR, 28(8), 2001, pp. 769-774

Authors: Gandhi, MK Egner, W Sizer, L Inman, I Zambon, M Craig, JIO Marcus, RE
Citation: Mk. Gandhi et al., Antibody responses to vaccinations given within the first two years after transplant are similar between autologous peripheral blood stem cell and bone marrow transplant recipients, BONE MAR TR, 28(8), 2001, pp. 775-781

Authors: Nishio, M Nakao, S Endo, T Fujimoto, K Takashima, H Sakai, T Bacigalupo, A Koike, T Sawada, K
Citation: M. Nishio et al., Successful non-myeloablative stem cell transplantation for a heavily transfused woman with severe aplastic anemia complicated by heart failure, BONE MAR TR, 28(8), 2001, pp. 783-785
Risultati: 1-25 | 26-50 | 51-75 | 76-100 | >>